Inhibition of RANKL: a new approach to the treatment of osteoporosis

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.8, 2006-06, pp. : 1097-1100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Wnt signalling pathway: a new target for the treatment of osteoporosis

By Rawadi Georges Roman-Roman Sergio

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1063-1077

Informa Healthcare

Access to resources Recommend Favorite

Strontium ranelate: a new paradigm in the treatment of osteoporosis

By Reginster Jean-Yves Lecart Marie-Paule Deroisy Rita Lousberg Christian

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 7, 2004-07 ,pp. : 857-864

Informa Healthcare

Access to resources Recommend Favorite

Piper Sarmentosum: A New Hope for the Treatment of Osteoporosis

Current Drug Targets, Vol. 14, Iss. 14, 2013-01 ,pp. : 1675-1682

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Inhibition of Interleukin-8 (CXCL8) as a New Approach for the Prevention and Treatment of Several Human Diseases

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 2, Iss. 1, 2003-03 ,pp. : 67-79

Bentham Science Publishers

Access to resources Recommend Favorite

Cathepsin K Inhibitors: A Novel Target but Promising Approach in the Treatment of Osteoporosis

Current Drug Targets, Vol. 14, Iss. 13, 2013-12 ,pp. : 1591-1600

Bentham Science Publishers

Access to resources Recommend Favorite